Please try another search
Medpace Research, Inc., a drug development company, focuses on developing novel therapies for kidney disease. It develops Pyridorin (pyridoxamine dihydrochoride), a therapeutic agent, treatment of diabetic nephropathy. Medpace Research, Inc. was formerly known as NephroGenex, Inc. and changed its name to Medpace Research, Inc. in June 2018. The company was founded in 2004 and is headquartered in Raleigh, North Carolina.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review